AMETEK, Inc. $AME Shares Sold by Praxis Investment Management Inc.

Key Points

• Praxis Investment Management Inc. reduced its stake in AMETEK, Inc. by 27.8%, selling 1,540 shares during the 2nd quarter, leaving them with 4,000 shares worth about $724,000.
• AMETEK reported quarterly earnings of $1.78 per share, exceeding analysts' expectations, with a revenue of $1.78 billion, up 2.5% compared to last year.
• Several analysts have raised their target prices for AMETEK, with Royal Bank of Canada increasing its target to $212 and DA Davidson to $215, reflecting a positive outlook on the stock.

Praxis Investment Management Inc. reduced its stake in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 27.8% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 4,000 shares of the technology company's stock after selling 1,540 shares during the period. Praxis Investment Management Inc.'s holdings in AMETEK were worth $724,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bares Capital Management Inc. acquired a new stake in AMETEK during the 1st quarter worth about $26,000. ST Germain D J Co. Inc. grew its position in AMETEK by 628.6% during the 2nd quarter. ST Germain D J Co. Inc. now owns 153 shares of the technology company's stock worth $28,000 after purchasing an additional 132 shares during the period. Olde Wealth Management LLC acquired a new stake in AMETEK during the 1st quarter worth about $29,000. Annis Gardner Whiting Capital Advisors LLC grew its position in shares of AMETEK by 57.7% during the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after acquiring an additional 71 shares during the period. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of AMETEK during the 1st quarter valued at about $42,000. 87.43% of the stock is owned by institutional investors and hedge funds.

AMETEK Trading Up 0.6%

Shares of AMETEK stock opened at $185.66 on Friday. The firm has a market capitalization of $42.88 billion, a PE ratio of 29.90, a P/E/G ratio of 2.65 and a beta of 1.11. AMETEK, Inc. has a twelve month low of $145.02 and a twelve month high of $198.33. The firm's 50-day moving average price is $185.69 and its 200 day moving average price is $178.30. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15.

AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share for the quarter, beating analysts' consensus estimates of $1.69 by $0.09. The firm had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.74 billion. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. AMETEK's quarterly revenue was up 2.5% compared to the same quarter last year. During the same period last year, the company posted $1.66 EPS. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. On average, sell-side analysts predict that AMETEK, Inc. will post 7.15 EPS for the current fiscal year.

AMETEK Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Monday, September 15th were paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Monday, September 15th. AMETEK's dividend payout ratio (DPR) is 19.97%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Royal Bank Of Canada raised their target price on AMETEK from $209.00 to $212.00 and gave the company an "outperform" rating in a research report on Friday, August 1st. DA Davidson raised their target price on AMETEK from $210.00 to $215.00 and gave the company a "buy" rating in a research report on Friday, August 1st. KeyCorp raised their target price on AMETEK from $195.00 to $205.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Robert W. Baird raised their target price on AMETEK from $190.00 to $198.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Finally, Melius cut AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price on the stock. in a research report on Monday, July 14th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $207.42.

AMETEK Company Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.